Classification Guidance Final Comments

The CPC’s comment letter in response to the Draft Guidance for Industry and FDA Staff – Classification of Products as Drugs and Devices and Additional Product Classification Issues wherein we requested the Agency ensure the consistent and appropriate regulation of similar products.